Hidradenitis suppurativa (HS) is a cutaneous disease affecting apocrine-gland-bearing skin. The term is a misnomer: while there is no denying its suppurative nature, HS is almost certainly not initiated by infection and is probably not a condition primarily affecting sweat glands. The absence of a con®rmatory test or of speci®c characteristics for diagnosis make a de®nition dif®cult. Accepted features are chronicity, recurrent abscesses, sinus formation, scarring and multifocal involvementÐin the axillae and the anogenital regions.
CLINICAL CHARACTERISTICS
Lesions begin as`blind' boils, most commonly at or soon after puberty. The abscesses tend to be deep and rounded with no pointing or central necrosis (unlike staphylococcal furunculosis). In the ®rst instance axillae and/or anogenital regions are involved, usually with remarkable symmetry. Recurrent lesions in the same vicinity lead to sinus tract formation,`bridged' scarring and`tombstone' comedones. With progression of the disease other isolated lesions develop, particularly at sites of shearingÐsubmammary regions in women, nape of neck, waistband and inner thighs.
Anogenital involvement most commonly affects the groins with extension to inguinal regions, mons pubis, inner thighs and sides of scrotum. The perineum, buttocks and perianal folds are often included. The sinuses can dissect deep into tissue, involving muscle, fascia and bowel and forming a labyrinth of tracts in advanced cases.
Acne (particularly of conglobate type), pilonidal sinus and chronic scalp folliculitis frequently coexist, giving rise to the term`follicular occlusion tetrad' 1 . In women, the condition frequently¯ares premenstrually and following pregnancy and it sometimes eases during pregnancy and after the menopause; these observations incriminate sex hormones 2 . Children are never affected unless they have precocious puberty.
Women are affected three times as often as men; there is no substance in the belief that women are more predisposed to axillary disease and men to anogenital disease. A point prevalence study in Denmark revealed the condition in 4.1% of a young adult population 3 . It has a peak incidence in the second and third decades declining rapidly by the ®fth decade.
PATHOLOGY/PATHOGENESIS
Sinus tract formation has been designated the hallmark of HS. In a study of 36 patients, two-thirds had follicular lesions compatible with occlusion, whereas primary apocrinitis, previously suggested as the typical histological feature, was present in only 5% 4 . Apocrine involvement from nearby in¯ammation was seen in 17%. On the basis of these histological ®ndings and others 5 , HS is now considered an in¯ammatory disease originating from the hair follicle. Follicular rupture spills contents, including keratin and bacteria, into surrounding dermis. This excites a vigorous chemotactic response and abscess formation. Epithelial strands are generated, possibly from ruptured follicular epithelium, to form sinus tracts. Genetics may be contributory: patients report cases more frequently among their relatives than do controls and autosomal dominant inheritance has been reported 5 . Despite the apparent strong clinical in¯uence of sex hormones most patients have normal androgen pro®les 2 ; moreover, apocrine glands, unlike sebaceous glands, are not androgen-sensitive 7 . Bacteria probably contribute to the pathogenesis secondarily, much as they do in acne. In the early stages pus is usually sterile. With disease progression various pathogens can be found, including Staphylococcus aureus, Streptococcus milleri and Chlamydia trachomatis 8 .
DIFFERENTIAL DIAGNOSIS
In the early stages, distinction from a septic furunculosis or in¯amed epidermoid cyst may be dif®cult, but with chronicity characteristic features including sinuses, scarring and comedones become apparent. Steatocystoma multiplex may result in a picture indistinguishable from HS, but telltale non-in¯amed cysts should be evident. Crohn's disease may be a source of confusion for anogenital disease, and other conditions including cryptoglandular anal ®stula, pilonidal sinus, tuberculosis, actinomycosis, lymphogranuloma venereum and granuloma inguinale must all be considered 9 . HS itself very rarely involves the anal canal and, if it does, tracks subcutaneously rather than across the sphincter; it never tracks above the dentate line 10 .
MEDICAL TREATMENT
Current practice is derived mainly from empirical attempts to control the disease. Only topical clindamycin has been shown to have an effect in a double-blind placebocontrolled study 11 . Antibiotics such as oral clindamycin 300 mg twice daily, if used early, can induce remission but the condition is very likely to relapse with time. If speci®c pathogens such as anaerobes are isolated, then an appropriate antibiotic can be selected, but for how long it should be used is unknown; again, relapse is likely. General measures that reduce pressure and shearing forces at affected sites are advisable. Obese patients should be helped to lose weight 12 . Hormonal therapy with cyproterone acetate and ethinyloestradiol proved effective in one randomized controlled trial 13 but doses were high and continued use raises safety concerns. Steroid therapy has its advocates but a common experience is that an initial anti-in¯ammatory response is followed by relapse. Intralesional steroids can be particularly useful for localized disease, if the drug can be prevented from escaping via the sinuses.
Oral immunosuppressive agents such as cyclosporin have been tried 14 .
Another approach, based on the apparent relationship between acne and hidradenitis, is to use retinoids but no randomized controlled trial has been done. Hidradenitis shows little sign of improvement with isotretinoin whereas acetretin 25 mg twice daily does seem to be effective 15 . This is understandable when we remember that sebaceous gland function is normal in HS 18 : isotretinoin mainly affects sebaceous glands whereas acetretin acts more on keratinization. Interestingly, cimetidine has been noted to ameliorate the condition. Histamine receptors are found in the skin and the drug has well documented antiandrogenic effects. There are no published clinical trials on its use, however.
SURGICAL TREATMENT
The principle of surgical treatment for HS is that it should be less debilitating than the condition itself. Interventions range from simple incision and drainage of acute abscesses to radical excision of all apocrine-bearing tissue 17 . The recurrence rate is proportional to the radicality of surgery. Drainage alone carries a recurrence rate of up to 100% with a median interval to recurrence of three months; radical excision has a recurrence rate of about 25% at a median interval of twenty months 18 . Careful lay-open of all tracks, possibly as a staged procedure according to geographical distribution, is seen by many clinicians and patients as an appropriate compromise between the surgical extremes. The dif®culty of dealing with the defect created by radical surgery has led to the use of split skin grafts and rotation¯aps. Primary closure is rarely possible. Experience in the surgical management of anal ®stulae has shown that, after wide lay-open of extrasphincteric tracks ramifying through the buttocks, healing by secondary intention can give a very satisfactory cosmetic result, though it takes longer. The creation of a defunctioning stoma is only occasionally necessary, when faecal ef¯ux interferes with wound management.
CONCLUSION
A likely mechanism in HS is that shearing forces, acting on large terminal follicles, in some way disrupt keratinization and so lead to follicular plugging and rupture. Genetic factors and perhaps hormonal priming of the follicle may predispose, with apocrine-gland-bearing skin particularly vulnerable. A reversible stage to the disease may exist but, once follicular rupture has occurred and sinus tracts have formed, the disease enters a more pernicious and irreversible stage. 
